Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2362430
Max Phase: Preclinical
Molecular Formula: C27H33ClN4O8S2
Molecular Weight: 641.17
Molecule Type: Small molecule
Associated Items:
ID: ALA2362430
Max Phase: Preclinical
Molecular Formula: C27H33ClN4O8S2
Molecular Weight: 641.17
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1noc(C)c1S(=O)(=O)Nc1ccc2c(c1)C(=O)N([C@H](C)CO)C[C@@H](C)[C@H](CN(C)S(=O)(=O)c1ccc(Cl)cc1)O2
Standard InChI: InChI=1S/C27H33ClN4O8S2/c1-16-13-32(17(2)15-33)27(34)23-12-21(30-41(35,36)26-18(3)29-40-19(26)4)8-11-24(23)39-25(16)14-31(5)42(37,38)22-9-6-20(28)7-10-22/h6-12,16-17,25,30,33H,13-15H2,1-5H3/t16-,17-,25+/m1/s1
Standard InChI Key: NTUSSASAJLMJNB-BFIDETRKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 641.17 | Molecular Weight (Monoisotopic): 640.1428 | AlogP: 3.29 | #Rotatable Bonds: 9 |
Polar Surface Area: 159.35 | Molecular Species: ACID | HBA: 9 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 12 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 6.25 | CX Basic pKa: 0.20 | CX LogP: 1.91 | CX LogD: 1.15 |
Aromatic Rings: 3 | Heavy Atoms: 42 | QED Weighted: 0.36 | Np Likeness Score: -1.35 |
1. PubChem BioAssay data set, |
2. Dockendorff C, Faloon PW, Pu J, Yu M, Johnston S, Bennion M, Penman M, Nieland TJ, Dandapani S, Perez JR, Munoz B, Palmer MA, Schreiber SL, Krieger M.. (2015) Benzo-fused lactams from a diversity-oriented synthesis (DOS) library as inhibitors of scavenger receptor BI (SR-BI)-mediated lipid uptake., 25 (10): [PMID:25900219] [10.1016/j.bmcl.2015.03.073] |
Source(2):